Author:
Gupta Shyam L.,Saini Surendra,Saini Pratibha,Dandia Anshu,Ameta K. L.,Parewa Vijay
Publisher
Springer Nature Singapore
Reference86 articles.
1. Ahmet MT, Douglas KT, Silver J et al (1986) Iron and haem complexation studies of 2, 3-dihydro-1H-imidazo (1,2-b) pyrazole (IMPY, NSC 51143), a tumour cell ribonucleotide reductase inhibitor. Anti-Cancer Drug Des 1:189–195
2. Amnerkar ND, Bhusari KP (2010) Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. Eur J Med Chem 45:149–159
3. Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM (2009) Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 44:2632–2635
4. Asad M, Khan SA, Arshad MN et al (2021) Design and synthesis of novel pyrazoline derivatives for their spectroscopic, single crystal X-ray and biological studies. J Mol Struct 1234:130131
5. Annes SB, Vairaprakash P, Ramesh S (2018) TfOH mediated intermolecular electrocyclization for the synthesis of pyrazolines and its application in alkaloid synthesis. RSC Adv 8:30071–30075